Personalized omalizumab treatment improves clinical benefit in patients with chronic spontaneous urticaria

J Allergy Clin Immunol. 2018 Dec;142(6):1992-1994. doi: 10.1016/j.jaci.2018.07.032. Epub 2018 Aug 23.

¹ Centre for Human Drug Research, Leiden, The Netherlands; Department of Dermatology Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
² Department of Internal Medicine, Allergology, Erasmus Medical Center, Rotterdam, The Netherlands.
³ Centre for Human Drug Research, Leiden, The Netherlands; Department of Dermatology Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. Electronic address: m.b.a.vandoorn@erasmusmc.nl.

No abstract available

Publication types